These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10385072)

  • 1. Cardiopulmonary dysfunction in cirrhosis.
    Liu H; Lee SS
    J Gastroenterol Hepatol; 1999 Jun; 14(6):600-8. PubMed ID: 10385072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cirrhotic cardiomyopathy.
    Al Hamoudi W; Lee SS
    Ann Hepatol; 2006; 5(3):132-9. PubMed ID: 17060868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy.
    Ma Z; Lee SS; Meddings JB
    J Hepatol; 1997 Apr; 26(4):904-12. PubMed ID: 9126806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhotic cardiomyopathy.
    Milani A; Zaccaria R; Bombardieri G; Gasbarrini A; Pola P
    Dig Liver Dis; 2007 Jun; 39(6):507-15. PubMed ID: 17383244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocardiac disorders : Interactions between two organ systems].
    Horvatits T; Drolz A; Rutter K; Roedl K; Kluge S; Fuhrmann V
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):447-52. PubMed ID: 26070920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cirrhotic cardiomyopathy.
    Alqahtani SA; Fouad TR; Lee SS
    Semin Liver Dis; 2008 Feb; 28(1):59-69. PubMed ID: 18293277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogies and differences between cirrhotic cardiomyopathy and hepatopulmonary syndrome.
    Zardi EM; Giorgi C; Dobrina A; Vecile E; Zardi DM
    Med Res Rev; 2021 Mar; 41(2):739-753. PubMed ID: 33174630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients.
    Voiosu AM; Daha IC; Voiosu TA; Mateescu BR; Dan GA; Băicuş CR; Voiosu MR; Diculescu MM
    Liver Int; 2015 Dec; 35(12):2547-55. PubMed ID: 25974637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhotic cardiomyopathy and liver transplantation.
    Myers RP; Lee SS
    Liver Transpl; 2000 Jul; 6(4 Suppl 1):S44-52. PubMed ID: 10915191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
    Liu H; Ma Z; Lee SS
    Gastroenterology; 2000 May; 118(5):937-44. PubMed ID: 10784593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatopulmonary syndrome: relationship with liver dysfunction and systemic hemodynamic disorder].
    Alonso Martínez JL; Zozaya Urmeneta JM; García Sanchotena JL; Olaz-Preciado F; Estébanez-Estébanez C; Berjón-Reyero J
    Med Clin (Barc); 2004 Nov; 123(19):721-5. PubMed ID: 15574284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatopulmonary syndrome and portopulmonary hypertension: what's new?
    Colle I; Van Steenkiste C; Geerts A; Van Vlierberghe H
    Acta Gastroenterol Belg; 2007; 70(2):203-9. PubMed ID: 17715635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhotic cardiomyopathy.
    Ruiz-del-Árbol L; Serradilla R
    World J Gastroenterol; 2015 Nov; 21(41):11502-21. PubMed ID: 26556983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatopulmonary syndrome in liver cirrhosis].
    Culafić Dj; Perisić M; Rebić P
    Srp Arh Celok Lek; 2000; 128(7-8):271-5. PubMed ID: 11089435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats.
    Ma Z; Miyamoto A; Lee SS
    Gastroenterology; 1996 Apr; 110(4):1191-8. PubMed ID: 8613009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome.
    Cremona G; Higenbottam TW; Mayoral V; Alexander G; Demoncheaux E; Borland C; Roe P; Jones GJ
    Eur Respir J; 1995 Nov; 8(11):1883-5. PubMed ID: 8620957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats.
    Sztrymf B; Rabiller A; Nunes H; Savale L; Lebrec D; Le Pape A; de Montpreville V; Mazmanian M; Humbert M; Hervé P
    Eur Respir J; 2004 May; 23(5):752-8. PubMed ID: 15176692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Respiratory functional impairment in patients with liver cirrhosis].
    Siemieniako A; Łapiński TW; Flisiak R
    Pol Merkur Lekarski; 2010 Apr; 28(166):319-22. PubMed ID: 20491346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.
    Liu H; Gaskari SA; Lee SS
    World J Gastroenterol; 2006 Feb; 12(6):837-42. PubMed ID: 16521209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cirrhotic cardiomyopathy: a cardiologist's perspective.
    Gassanov N; Caglayan E; Semmo N; Massenkeil G; Er F
    World J Gastroenterol; 2014 Nov; 20(42):15492-8. PubMed ID: 25400434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.